{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:33:00Z","timestamp":1788849180670,"version":"build-2803163510"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11064-023-03868-1","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:03:29Z","timestamp":1675479809000},"page":"1631-1647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development"],"prefix":"10.1007","volume":"48","author":[{"given":"Shubham","family":"Upadhayay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narhari Gangaram","family":"Yedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Chandolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhsharan","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Koshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"issue":"5","key":"3868_CR1","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.52711\/0974-360X.2021.00435","volume":"14","author":"S Gupta","year":"2021","unstructured":"Gupta S, Sharma B (2021) Neuroprotective potential of Cilostazol in 3-NP provoked Huntington\u2019s disease-associated symptoms. Res J Pharm Technol 14(5):2472\u20132478","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"3868_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbr.2009.08.028","volume":"206","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington\u2019s like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206(1):38\u201346","journal-title":"Behav Brain Res"},{"issue":"2","key":"3868_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.12082","volume":"124","author":"N Herrera-Mundo","year":"2013","unstructured":"Herrera-Mundo N, Sitges M (2013) Vinpocetine and \u03b1-tocopherol prevent the increase in DA and oxidative stress induced by 3-NPA in striatum isolated nerve endings. J Neurochem 124(2):233\u2013240","journal-title":"J Neurochem"},{"key":"3868_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.exger.2017.06.009","volume":"96","author":"A Silva-Palacios","year":"2017","unstructured":"Silva-Palacios A et al (2017) 3-NP-induced Huntington\u2019s-like disease impairs Nrf2 activation without loss of cardiac function in aged rats. Exp Gerontol 96:89\u201398","journal-title":"Exp Gerontol"},{"issue":"3","key":"3868_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M et al (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39(3):385\u2013389","journal-title":"Ann Neurol"},{"issue":"10","key":"3868_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ et al (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16(10):529\u2013546","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3868_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41514-020-00054-3","volume":"7","author":"K Be\u010danovi\u0107","year":"2021","unstructured":"Be\u010danovi\u0107 K et al (2021) Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease. NPJ Aging and Mech Dis 7(1):1\u201314","journal-title":"NPJ Aging and Mech Dis"},{"key":"3868_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","volume":"217","author":"U R\u00fcb","year":"2015","unstructured":"R\u00fcb U et al (2015) The neuropathology of Huntington\u2019s disease: classical findings, recent developments and correlation to functional neuroanatomy. Adv Anat Embryol Cell Biol 217:1\u2013146","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"1","key":"3868_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0972-2327.175425","volume":"19","author":"KB Bhattacharyya","year":"2016","unstructured":"Bhattacharyya KB (2016) The story of George Huntington and his disease. Ann Indian Acad Neurol 19(1):25\u201328","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"3868_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0166-2236(95)93943-R","volume":"18","author":"RL Albin","year":"1995","unstructured":"Albin RL, Tagle DA (1995) Genetics and molecular biology of Huntington\u2019s disease. Trends Neurosci 18(1):11\u201314","journal-title":"Trends Neurosci"},{"issue":"6","key":"3868_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"key":"3868_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ebiom.2018.03.031","volume":"31","author":"JK Lee","year":"2018","unstructured":"Lee JK et al (2018) Effect of trinucleotide repeats in the Huntington\u2019s gene on intelligence. EBioMedicine 31:47\u201353","journal-title":"EBioMedicine"},{"issue":"9","key":"3868_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/jnnp-2015-312413","volume":"87","author":"F Begeti","year":"2016","unstructured":"Begeti F et al (2016) Hippocampal dysfunction defines disease onset in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 87(9):975\u2013981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3868_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10495-020-01645-x","volume":"26","author":"S Ahmed","year":"2021","unstructured":"Ahmed S et al (2021) Potential role of TrkB agonist in neuronal survival by promoting CREB\/BDNF and PI3K\/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death. Apoptosis 26(1):52\u201370","journal-title":"Apoptosis"},{"issue":"3","key":"3868_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.12965\/jer.150212","volume":"11","author":"E-S Ji","year":"2015","unstructured":"Ji E-S et al (2015) Treadmill exercise enhances spatial learning ability through suppressing hippocampal apoptosis in Huntington\u2019s disease rats. J Exerc Rehabil 11(3):133","journal-title":"J Exerc Rehabil"},{"issue":"5","key":"3868_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE et al (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41(5):646\u2013653","journal-title":"Ann Neurol"},{"issue":"11","key":"3868_CR17","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.3390\/ijms22115444","volume":"22","author":"OO Gonchar","year":"2021","unstructured":"Gonchar OO et al (2021) C60 fullerene reduces 3-nitropropionic acid-induced oxidative stress disorders and mitochondrial dysfunction in rats by modulation of p53, Bcl-2 and Nrf2 targeted proteins. Int J Mol Sci 22(11):5444","journal-title":"Int J Mol Sci"},{"key":"3868_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","volume":"155","author":"S Jamwal","year":"2016","unstructured":"Jamwal S, Kumar P (2016) Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters. Physiol Behav 155:180\u2013187","journal-title":"Physiol Behav"},{"issue":"1","key":"3868_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP et al (2015) Huntington disease. Nat Rev Dis Primers 1(1):1\u201321","journal-title":"Nat Rev Dis Primers"},{"key":"3868_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s13311-021-01023-8","volume":"18","author":"DA Simmons","year":"2021","unstructured":"Simmons DA et al (2021) Neuroimaging, urinary, and plasma biomarkers of treatment response in Huntington\u2019s Disease: preclinical evidence with the p75 NTR Ligand LM11A-31. Neurotherapeutics 18:1039\u20131063","journal-title":"Neurotherapeutics"},{"issue":"10","key":"3868_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1745-7254.2006.00410.x","volume":"27","author":"LH Wang","year":"2006","unstructured":"Wang LH, Qin ZH (2006) Animal models of Huntington\u2019s disease: implications in uncovering pathogenic mechanisms and developing therapies 1. Acta Pharmacol Sin 27(10):287\u20131302","journal-title":"Acta Pharmacol Sin"},{"issue":"2\u20133","key":"3868_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","volume":"244","author":"M Ahuja","year":"2008","unstructured":"Ahuja M, Bishnoi M, Chopra K (2008) Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 244(2\u20133):111\u2013122","journal-title":"Toxicology"},{"issue":"1","key":"3868_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainres.2006.08.035","volume":"1118","author":"S-T Lee","year":"2006","unstructured":"Lee S-T et al (2006) Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington\u2019s disease. Brain Res 1118(1):199\u2013207","journal-title":"Brain Res"},{"key":"3868_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2014.11.036","volume":"586","author":"V Ranju","year":"2015","unstructured":"Ranju V et al (2015) Memantine exerts functional recovery by improving BDNF and GDNF expression in 3-nitropropionic acid intoxicated mice. Neurosci Lett 586:1\u20137","journal-title":"Neurosci Lett"},{"issue":"1","key":"3868_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5214\/ans.0972.7531.220104","volume":"22","author":"S Shetty","year":"2015","unstructured":"Shetty S et al (2015) Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid. Ann Neurosci 22(1):11","journal-title":"Ann Neurosci"},{"issue":"1","key":"3868_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.029","volume":"674","author":"DK Bhateja","year":"2012","unstructured":"Bhateja DK et al (2012) Peroxisome proliferator-activated receptor-\u03b1 activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 674(1):33\u201343","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"3868_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejphar.2013.06.035","volume":"714","author":"T Thakur","year":"2013","unstructured":"Thakur T et al (2013) Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats. Eur J Pharmacol 714(1\u20133):515\u2013521","journal-title":"Eur J Pharmacol"},{"key":"3868_CR28","unstructured":"clinicaltrials.gov. Clinical Trial results. Available from: https:\/\/clinicaltrials.gov\/ct2\/home."},{"issue":"3","key":"3868_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JHD-200411","volume":"9","author":"L Delfino","year":"2020","unstructured":"Delfino L et al (2020) Rab8 promotes mutant HTT aggregation, reduces neurodegeneration, and ameliorates behavioural alterations in a Drosophila model of Huntington\u2019s disease. J Huntington\u2019s Dis 9(3):253\u2013263","journal-title":"J Huntington's Dis"},{"issue":"1386","key":"3868_CR30","first-page":"981","volume":"354","author":"J-HJ Cha","year":"1999","unstructured":"Cha J-HJ et al (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philosophical transactions of the royal society of London. Series B: Biolo Sci 354(1386):981\u2013989","journal-title":"Series B: Biolo Sci"},{"issue":"1","key":"3868_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-4159.1976.tb04437.x","volume":"26","author":"P McGeer","year":"1976","unstructured":"McGeer P, McGeer E (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson\u2019s disease and Huntington\u2019s chorea. J Neurochem 26(1):65\u201376","journal-title":"J Neurochem"},{"issue":"10","key":"3868_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/jmf.2012.2698","volume":"16","author":"Y Binawade","year":"2013","unstructured":"Binawade Y, Jagtap A (2013) Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington\u2019s disease-like symptoms: possible behavioral, biochemical, and cellular alterations. J Med Food 16(10):934\u2013943","journal-title":"J Med Food"},{"key":"3868_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2015.12.032","volume":"771","author":"S Datta","year":"2016","unstructured":"Datta S et al (2016) Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: possible neurotransmitters and neuroinflammation modulation. Eur J Pharmacol 771:229\u2013235","journal-title":"Eur J Pharmacol"},{"issue":"4170","key":"3868_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/164575b0","volume":"164","author":"C Carter","year":"1949","unstructured":"Carter C, McChesney W (1949) Hiptagenic acid identified as \u03b2-nitropropionic acid. Nature 164(4170):575\u2013576","journal-title":"Nature"},{"key":"3868_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-59259-692-8_2","volume-title":"Mitochondrial inhibitors and neurodegenerative disorders","author":"BF Hamilton","year":"2000","unstructured":"Hamilton BF, Gould DH, Gustine DL (2000) History of 3-nitropropionic acid. Mitochondrial inhibitors and neurodegenerative disorders. Springer, Berlin, pp 21\u201333"},{"issue":"4","key":"3868_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/15563659509028924","volume":"33","author":"L Ming","year":"1995","unstructured":"Ming L (1995) Moldy sugarcane poisoning\u2014a case report with a brief review. J Toxicol Clin Toxicol 33(4):363\u2013367","journal-title":"J Toxicol Clin Toxicol"},{"key":"3868_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuro.2021.08.016","volume":"87","author":"FTT Antunes","year":"2021","unstructured":"Antunes FTT et al (2021) Neuroprotective effects of the CTK 01512\u20132 toxin against neurotoxicity induced by 3-nitropropionic acid in rats. Neurotoxicology 87:30\u201342","journal-title":"Neurotoxicology"},{"key":"3868_CR38","doi-asserted-by":"publisher","first-page":"731483","DOI":"10.3389\/fphar.2021.731483","volume":"12","author":"SM Shawki","year":"2021","unstructured":"Shawki SM et al (2021) Liraglutide improves cognitive and neuronal function in 3-NP Rat model of Huntington\u2019s disease. Front Pharmacol 12:731483","journal-title":"Front Pharmacol"},{"issue":"3","key":"3868_CR39","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.crphar.2022.100130","volume":"20","author":"Chandolia","year":"2022","unstructured":"Chandolia et al (2022) Neuroprotective effect of silymarin against 3-nitropropionic acid-induced neurotoxicity in rats. Curr Res Pharmacol Drug Discov 20(3):100130","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"2","key":"3868_CR40","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s12035-014-9086-x","volume":"53","author":"D Colle","year":"2016","unstructured":"Colle D et al (2016) Succinobucol, a lipid-lowering drug, protects against 3-nitropropionic acid-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y cells via upregulation of glutathione levels and glutamate cysteine ligase activity. Mol Neurobiol 53(2):1280\u20131295","journal-title":"Mol Neurobiol"},{"key":"3868_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.toxicon.2021.03.001","volume":"195","author":"FTT Antunes","year":"2021","unstructured":"Antunes FTT et al (2021) In vivo treatment with a subacute low dose of 3-nitropropionic acid does not induce genotoxicity or mutagenicity in rats. Toxicon 195:20\u201323","journal-title":"Toxicon"},{"issue":"1","key":"3868_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2018.1484771","volume":"126","author":"D Calder\u00f3n Guzm\u00e1n","year":"2020","unstructured":"Calder\u00f3n Guzm\u00e1n D et al (2020) Folic acid increases levels of GHS in brain of rats with oxidative stress induced with 3-nitropropionic acid. Arch Physiol Biochem 126(1):1\u20136","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"3868_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.56808\/3027-7922.2468","volume":"45","author":"S Deepa","year":"2021","unstructured":"Deepa S et al (2021) Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington's disease. Thai J Pharm Sci 45(1):16\u201323","journal-title":"Thai J Pharm Sci"},{"issue":"9","key":"3868_CR44","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00210-021-02106-1","volume":"394","author":"P Sharma","year":"2021","unstructured":"Sharma P, Kumar M, Bansal N (2021) Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington\u2019s disease. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 394(9):1917\u20131928","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"3868_CR45","first-page":"2347","volume":"14","author":"D Jaglan","year":"2018","unstructured":"Jaglan D, Singh Bindra C (2018) Evaluating neuroprotective effects of ascorbic acid against 3-nitropropionic acid induced Huntington\u2019s disease in rats: possible involvement of gabaareceptors. Int J Res Appl Nat Soc Sci 14:2347\u20134580","journal-title":"Int J Res Appl Nat Soc Sci"},{"issue":"1","key":"3868_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-019-00086-y","volume":"37","author":"MS Abdelfattah","year":"2020","unstructured":"Abdelfattah MS et al (2020) Rutin and selenium co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington\u2019s disease. Neurotox Res 37(1):77\u201392","journal-title":"Neurotox Res"},{"issue":"3","key":"3868_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/jmf.2008.0028","volume":"12","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington\u2019s disease. J Med Food 12(3):591\u2013600","journal-title":"J Med Food"},{"issue":"2\u20133","key":"3868_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","volume":"674","author":"P Kumar","year":"2012","unstructured":"Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674(2\u20133):265\u2013274","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"3868_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/FBP.0b013e32833a5bf4","volume":"21","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kalonia H, Kumar A (2010) Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington\u2019s disease. Behav Pharmacol 21(3):217\u2013230","journal-title":"Behav Pharmacol"},{"issue":"6","key":"3868_CR50","first-page":"309","volume":"50","author":"S Mehan","year":"2018","unstructured":"Mehan S et al (2018) Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: restoration of coenzyme-Q10-mediated mitochondrial dysfunction. J Pharmacol 50(6):309","journal-title":"J Pharmacol"},{"issue":"1\u20132","key":"3868_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","volume":"697","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV et al (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington\u2019s disease. Brain Res 697(1\u20132):254\u2013257","journal-title":"Brain Res"},{"key":"3868_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.dib.2017.07.004","volume":"14","author":"A-H Norberto","year":"2017","unstructured":"Norberto A-H et al (2017) Raw data of the effects of Chlorogenic acid in 3-Nitropropionic acid induced toxicity and genotoxicity. Data Brief 14:123","journal-title":"Data Brief"},{"issue":"9","key":"3868_CR53","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/1028415X.2021.1913319","volume":"25","author":"M Salman","year":"2021","unstructured":"Salman M et al (2021) Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington\u2019s disease like symptoms in rats. Nut Neurosci 25(9):1898\u20131908","journal-title":"Nut Neurosci"},{"issue":"2","key":"3868_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5214\/ans.0972.7531.2006.130204","volume":"13","author":"P Kumar","year":"2006","unstructured":"Kumar P et al (2006) Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci 13(2):41\u201317","journal-title":"Ann Neurosci"},{"issue":"2","key":"3868_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12031-016-0801-0","volume":"60","author":"S Mu","year":"2016","unstructured":"Mu S et al (2016) Dihydromyricetin ameliorates 3NP-induced behavioral deficits and striatal injury in rats. J Mol Neurosci 60(2):267\u2013275","journal-title":"J Mol Neurosci"},{"issue":"1","key":"3868_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/1028415X.2020.1721645","volume":"25","author":"M Salman","year":"2020","unstructured":"Salman M, Tabassum H, Parvez S (2020) Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms. Nut Neurosci 25(1):100\u20131009","journal-title":"Nut Neurosci"},{"issue":"3","key":"3868_CR57","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","volume":"82","author":"MG Tadros","year":"2005","unstructured":"Tadros MG et al (2005) Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington\u2019s disease phenotype. Pharmacol Biochem Behav 82(3):574\u2013582","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"3868_CR58","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","volume":"33","author":"A Sidhu","year":"2018","unstructured":"Sidhu A et al (2018) Nicotinamide reverses behavioral impairments and provides neuroprotection in 3\u02d7 nitropropionic acid induced animal model ofHuntington\u2019s disease: implication of oxidative stress\u02d7 poly (ADP\u02d7 ribose) polymerase pathway. Metab Brain Dis 33(6):1911\u20131921","journal-title":"Metab Brain Dis"},{"key":"3868_CR59","doi-asserted-by":"publisher","first-page":"110368","DOI":"10.1016\/j.pnpbp.2021.110368","volume":"111","author":"MA Saad","year":"2021","unstructured":"Saad MA et al (2021) Nano-ivabradine averts behavioral anomalies in Huntington\u2019s disease rat model via modulating Rhes\/m-tor pathway. Prog Neuro-Psychopharmacol Biol Psychiatry 111:110368","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3868_CR60","doi-asserted-by":"publisher","DOI":"10.9734\/ejmp\/2020\/v31i530235","author":"G Bhatia","year":"2020","unstructured":"Bhatia G et al (2020) Protective effect of Andrographolide in 3-nitropropionic acid induced Huntington disease and associated neurodegenerative changes in rats. European J Med Plants. https:\/\/doi.org\/10.9734\/ejmp\/2020\/v31i530235","journal-title":"European J Med Plants"},{"issue":"3","key":"3868_CR61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000334273","volume":"9","author":"R Sandhir","year":"2012","unstructured":"Sandhir R et al (2012) N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegener Dis 9(3):145\u2013157","journal-title":"Neurodegener Dis"},{"key":"3868_CR62","doi-asserted-by":"publisher","first-page":"118076","DOI":"10.1016\/j.lfs.2020.118076","volume":"257","author":"AE El-Sahar","year":"2020","unstructured":"El-Sahar AE et al (2020) Dapagliflozin improves behavioral dysfunction of Huntington\u2019s disease in rats via inhibiting apoptosis-related glycolysis. Life Sci 257:118076","journal-title":"Life Sci"},{"key":"3868_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxicon.2020.05.012","volume":"183","author":"A Torabi","year":"2020","unstructured":"Torabi A et al (2020) The effect of 3-nitropropionic acid on behavioral dysfunction, neuron loss and gliosis in the brain of adult male rats: the case of prefrontal cortex, hippocampus and the cerebellum. Toxicon 183:44\u201350","journal-title":"Toxicon"},{"key":"3868_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neures.2020.12.002","volume":"170","author":"N Eskandari","year":"2021","unstructured":"Eskandari N et al (2021) Transplantation of human dental pulp stem cells compensates for striatal atrophy and modulates neuro-inflammation in 3-nitropropionic acid rat model of Huntington\u2019s disease. Neurosci Res 170:133\u2013144","journal-title":"Neurosci Res"},{"issue":"3","key":"3868_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13596-016-0237-7","volume":"16","author":"JO Bhangale","year":"2016","unstructured":"Bhangale JO, Acharya NS, Acharya SR (2016) Protective effect of Ficus religiosa (L.) against 3-nitropropionic acid induced Huntington disease. Orient Pharm Exp Med 16(3):165\u2013174","journal-title":"Orient Pharm Exp Med"},{"issue":"10","key":"3868_CR66","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s11064-018-2615-7","volume":"43","author":"P Liu","year":"2018","unstructured":"Liu P et al (2018) Tolfenamic acid attenuates 3-nitropropionic acid-induced biochemical alteration in mice. Neurochem Res 43(10):1938\u20131946","journal-title":"Neurochem Res"},{"issue":"9","key":"3868_CR67","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","volume":"42","author":"X Yang","year":"2021","unstructured":"Yang X et al (2021) Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum. Acta Pharmacol Sin 42(9):1409\u20131421","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"3868_CR68","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","volume":"74","author":"TA Alston","year":"1977","unstructured":"Alston TA, Mela L, Bright HJ (1977) 3-Nitropropionate, the toxic substance of <em>Indigofera<\/em>, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci 74(9):3767\u20133771","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3868_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0197-0186(95)00122-0","volume":"29","author":"JB Schulz","year":"1996","unstructured":"Schulz JB et al (1996) Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int 29(2):167\u2013171","journal-title":"Neurochem Int"},{"issue":"9","key":"3868_CR70","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3109\/15376516.2014.961216","volume":"24","author":"S Dhadde","year":"2014","unstructured":"Dhadde S, Durg S, Potadar P (2014) Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice. Toxicol Mech Methods 24(9):672\u2013678","journal-title":"Toxicol Mech Methods"},{"issue":"5","key":"3868_CR71","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/jat.4259","volume":"42","author":"H Bendiksen Skogvold","year":"2021","unstructured":"Bendiksen Skogvold H et al (2021) A pioneer study on human 3-nitropropionic acid intoxication: contributions from metabolomics. J Appl Toxicol 42(5):818\u2013829","journal-title":"J Appl Toxicol"},{"issue":"2","key":"3868_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","volume":"17","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Kumar P (2019) Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson\u2019s disease and Huntington\u2019s disease: a review. Curr Neuropharmacol 17(2):165\u2013175","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"3868_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/antiox9070577","volume":"9","author":"J Bono-Yag\u00fce","year":"2020","unstructured":"Bono-Yag\u00fce J et al (2020) Reactive species in Huntington disease: are they really the radicals you want to catch? Antioxidants 9(7):577","journal-title":"Antioxidants"},{"issue":"3","key":"3868_CR74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0304-3940(97)00514-4","volume":"230","author":"Z Binienda","year":"1997","unstructured":"Binienda Z, Kim CS (1997) Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration. Neurosci Lett 230(3):199\u2013201","journal-title":"Neurosci Lett"},{"issue":"5\u20136","key":"3868_CR75","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","volume":"17","author":"P Kumar","year":"2006","unstructured":"Kumar P et al (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17(5\u20136):485\u2013492","journal-title":"Behav Pharmacol"},{"issue":"3","key":"3868_CR76","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","volume":"21","author":"P Kumar","year":"2007","unstructured":"Kumar P et al (2007) Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. Fundam Clin Pharmacol 21(3):297\u2013306","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"3868_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","volume":"133","author":"BS Mandavilli","year":"2005","unstructured":"Mandavilli BS, Boldogh I, Van Houten B (2005) 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol Brain Res 133(2):215\u2013223","journal-title":"Mol Brain Res"},{"issue":"4\u20135","key":"3868_CR78","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.brainresbull.2012.01.003","volume":"87","author":"D Colle","year":"2012","unstructured":"Colle D et al (2012) Probucol modulates oxidative stress and excitotoxicity in Huntington\u2019s disease models in vitro. Brain Res Bull 87(4\u20135):397\u2013405","journal-title":"Brain Res Bull"},{"key":"3868_CR79","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejphar.2017.03.023","volume":"803","author":"SB Chidambaram","year":"2017","unstructured":"Chidambaram SB et al (2017) Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: Evidences from memantine and 3-aminobenzamide interventions. Eur J Pharmacol 803:148\u2013158","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"3868_CR80","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1523\/JNEUROSCI.21-14-05110.2001","volume":"21","author":"P Calabresi","year":"2001","unstructured":"Calabresi P et al (2001) Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 21(14):5110\u20135120","journal-title":"J Neurosci"},{"issue":"11\u201312","key":"3868_CR81","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne SE, Beal MF (2006) Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxid Redox Signal 8(11\u201312):2061\u20132073","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"3868_CR82","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1460-9568.2003.02806.x","volume":"18","author":"M Marti","year":"2003","unstructured":"Marti M et al (2003) Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington\u2019s disease. Eur J Neurosci 18(4):759\u2013767","journal-title":"Eur J Neurosci"},{"issue":"1","key":"3868_CR83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/exnr.2000.7428","volume":"164","author":"J Storgaard","year":"2000","unstructured":"Storgaard J et al (2000) 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate. Exp Neurol 164(1):227\u2013235","journal-title":"Exp Neurol"},{"issue":"5","key":"3868_CR84","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuro.2012.07.007","volume":"33","author":"ET Menze","year":"2012","unstructured":"Menze ET et al (2012) Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 33(5):1265\u20131275","journal-title":"Neurotoxicology"},{"issue":"2","key":"3868_CR85","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","volume":"32","author":"SN Suganya","year":"2017","unstructured":"Suganya SN, Sumathi T (2017) Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington\u2019s disease model in rats. Metab Brain Dis 32(2):471\u2013481","journal-title":"Metab Brain Dis"},{"key":"3868_CR86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuroscience.2012.07.060","volume":"227","author":"K Gopinath","year":"2012","unstructured":"Gopinath K, Sudhandiran G (2012) Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 227:134\u2013143","journal-title":"Neuroscience"},{"issue":"1","key":"3868_CR87","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-015-2525-9","volume":"409","author":"G Kulasekaran","year":"2015","unstructured":"Kulasekaran G, Ganapasam S (2015) Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem 409(1):199\u2013211","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3868_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2008.10.020","volume":"448","author":"J-E Park","year":"2008","unstructured":"Park J-E et al (2008) Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington\u2019s disease. Neurosci Lett 448(1):143\u2013147","journal-title":"Neurosci Lett"},{"issue":"10","key":"3868_CR89","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3109\/13880209.2014.984856","volume":"53","author":"J Malik","year":"2015","unstructured":"Malik J, Choudhary S, Kumar P (2015) Protective effect of Convolvulus pluricaulis standardized extract and its fractions against 3-nitropropionic acid-induced neurotoxicity in rats. Pharm Biol 53(10):1448\u20131457","journal-title":"Pharm Biol"},{"issue":"4","key":"3868_CR90","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1471-4159.2005.03253.x","volume":"94","author":"C Cleren","year":"2005","unstructured":"Cleren C et al (2005) Celastrol protects against MPTP-and 3-nitropropionic acid-induced neurotoxicity. J Neurochem 94(4):995\u20131004","journal-title":"J Neurochem"},{"issue":"5","key":"3868_CR91","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","volume":"57","author":"R Sandhir","year":"2010","unstructured":"Sandhir R, Mehrotra A, Kamboj SS (2010) Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 57(5):579\u2013587","journal-title":"Neurochem Int"},{"issue":"5","key":"3868_CR92","first-page":"706","volume":"60","author":"P Kumar","year":"2008","unstructured":"Kumar P, Kumar A (2008) Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats. Pharmacol Rep 60(5):706","journal-title":"Pharmacol Rep"},{"issue":"8","key":"3868_CR93","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s11064-015-1658-2","volume":"40","author":"S Singh","year":"2015","unstructured":"Singh S, Jamwal S, Kumar P (2015) Piperine enhances the protective effect of curcumin against 3-NP induced neurotoxicity: possible neurotransmitters modulation mechanism. Neurochem Res 40(8):1758\u20131766","journal-title":"Neurochem Res"},{"issue":"5","key":"3868_CR94","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10286020902862194","volume":"11","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kalonia H, Kumar A (2009) Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 11(5):439\u2013450","journal-title":"J Asian Nat Prod Res"},{"issue":"3","key":"3868_CR95","first-page":"139","volume":"1","author":"P Kumar","year":"2008","unstructured":"Kumar P, Kumar A (2008) Effects of root extract of Withania somnifera in 3-nitropropionic acid-induced cognitive dysfunction and oxidative damage in rats. Int J Health Res 1(3):139\u2013149","journal-title":"Int J Health Res"},{"key":"3868_CR96","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","volume":"2","author":"N Kaur","year":"2015","unstructured":"Kaur N et al (2015) Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Toxicol Rep 2:1222\u20131232","journal-title":"Toxicol Rep"},{"issue":"11","key":"3868_CR97","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/acschemneuro.8b00072","volume":"9","author":"C Lois","year":"2018","unstructured":"Lois C et al (2018) Neuroinflammation in Huntington\u2019s Disease: New Insights with 11C-PBR28 PET\/MRI. ACS Chem Neurosci 9(11):2563\u20132571","journal-title":"ACS Chem Neurosci"},{"key":"3868_CR98","doi-asserted-by":"publisher","first-page":"106587","DOI":"10.1016\/j.prostaglandins.2021.106587","volume":"157","author":"SM Razavi","year":"2021","unstructured":"Razavi SM et al (2021) Licofelone, a potent COX\/5-LOX inhibitor and a novel option for treatment of neurological disorders. Prostaglandins Other Lipid Mediat 157:106587","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"3868_CR99","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, Santamar\u00eda A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15(2):878\u2013916","journal-title":"Molecules"},{"key":"3868_CR100","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.nutr.24.012003.132446","volume":"25","author":"U Singh","year":"2005","unstructured":"Singh U, Devaraj S, Jialal I (2005) Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25:151\u2013174","journal-title":"Annu Rev Nutr"},{"issue":"2b","key":"3868_CR101","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","volume":"164","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Expression of Concern: Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington\u2019s Disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164(2b):644\u2013654","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3868_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000097627","volume":"79","author":"M Bishnoi","year":"2007","unstructured":"Bishnoi M et al (2007) Co-administration of acetyl-11-keto-\u03b2-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice. Pharmacology 79(1):34\u201341","journal-title":"Pharmacology"},{"issue":"6","key":"3868_CR103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12264-009-0513-3","volume":"25","author":"H Kalonia","year":"2009","unstructured":"Kalonia H et al (2009) Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. Neurosci Bull 25(6):343\u2013352","journal-title":"Neurosci Bull"},{"issue":"1","key":"3868_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/089771502753460196","volume":"19","author":"SD Hurley","year":"2002","unstructured":"Hurley SD, Olschowka JA, O\u2019Banion MK (2002) Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J Neurotrauma 19(1):1\u201315","journal-title":"J Neurotrauma"},{"key":"3868_CR105","doi-asserted-by":"crossref","unstructured":"Lima IVdA et al (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediat Inflamm 2012:1\u201313","DOI":"10.1155\/2012\/946813"},{"key":"3868_CR106","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","volume":"38","author":"M Jang","year":"2014","unstructured":"Jang M, Lee MJ, Cho I-H (2014) Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun 38:151\u2013165","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3868_CR107","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","volume":"17","author":"NH Sayed","year":"2020","unstructured":"Sayed NH et al (2020) Vildagliptin attenuates Huntington\u2019s disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17(1):252\u2013268","journal-title":"Neurotherapeutics"},{"issue":"3","key":"3868_CR108","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cge.12628","volume":"89","author":"T Vinther-Jensen","year":"2016","unstructured":"Vinther-Jensen T et al (2016) Psychiatric and cognitive symptoms in Huntington\u2019s disease are modified by polymorphisms in catecholamine regulating enzyme genes. Clin Genet 89(3):320\u2013327","journal-title":"Clin Genet"},{"issue":"12","key":"3868_CR109","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch ET, Raymond LA (2019) Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J Neurosci Res 97(12):1636\u20131654","journal-title":"J Neurosci Res"},{"issue":"2","key":"3868_CR110","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JHD-120039","volume":"1","author":"T Renoir","year":"2012","unstructured":"Renoir T, Argyropoulos A, Hannan AJ (2012) Antidepressant-like effect of the norepinephrine-dopamine reuptake inhibitor bupropion in a mouse model of Huntington\u2019s disease with dopaminergic dysfunction. J Huntington\u2019s Dis 1(2):261\u2013266","journal-title":"J Huntington's Dis"},{"issue":"2","key":"3868_CR111","first-page":"244","volume":"29","author":"RF Villar\u00e1n","year":"2008","unstructured":"Villar\u00e1n RF et al (2008) Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 29(2):244\u2013258","journal-title":"Neurotoxicology"},{"issue":"4","key":"3868_CR112","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0168-0102(97)01170-X","volume":"27","author":"H Nishino","year":"1997","unstructured":"Nishino H et al (1997) Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci Res 27(4):343\u2013355","journal-title":"Neurosci Res"},{"issue":"3","key":"3868_CR113","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.neuroscience.2009.03.083","volume":"161","author":"J Kraft","year":"2009","unstructured":"Kraft J et al (2009) In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience 161(3):940\u2013949","journal-title":"Neuroscience"},{"issue":"10","key":"3868_CR114","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/0269881110364269","volume":"25","author":"P Kumar","year":"2011","unstructured":"Kumar P, Kalonia H, Kumar A (2011) Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington\u2019s-like symptoms: a comparative study. J Psychopharmacol 25(10):1399\u20131411","journal-title":"J Psychopharmacol"},{"issue":"1","key":"3868_CR115","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","volume":"33","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33(1):100\u2013108","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"3868_CR116","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1755-5949.2012.00315.x","volume":"18","author":"BG Zhu","year":"2012","unstructured":"Zhu BG et al (2012) Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke. CNS Neurosci Ther 18(7):530\u2013535","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"3868_CR117","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/cns.12826","volume":"24","author":"M Garret","year":"2018","unstructured":"Garret M et al (2018) Alteration of GABA ergic neurotransmission in Huntington\u2019s disease. CNS Neurosci Ther 24(4):292\u2013300","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"3868_CR118","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.pnpbp.2007.12.017","volume":"32","author":"A Dhir","year":"2008","unstructured":"Dhir A, Akula KK, Kulkarni S (2008) Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. Prog Neuropsychopharmacol Biol Psychiatry 32(3):835\u2013843","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3868_CR119","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","volume":"9","author":"J Lewerenz","year":"2015","unstructured":"Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases\u2014what is the evidence? Front Neurosci 9:469","journal-title":"Front Neurosci"},{"issue":"3","key":"3868_CR120","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s12035-016-9822-5","volume":"54","author":"S Jamwal","year":"2017","unstructured":"Jamwal S, Kumar P (2017) L-theanine, a component of green tea prevents 3-nitropropionic acid (3-NP)-induced striatal toxicity by modulating nitric oxide pathway. Mol Neurobiol 54(3):2327\u20132337","journal-title":"Mol Neurobiol"},{"key":"3868_CR121","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbr.2014.01.048","volume":"264","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J et al (2014) Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. Behav Brain Res 264:91\u2013104","journal-title":"Behav Brain Res"},{"key":"3868_CR122","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2013.11.036","volume":"723","author":"P Kumar","year":"2014","unstructured":"Kumar P et al (2014) Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats. Eur J Pharmacol 723:38\u201345","journal-title":"Eur J Pharmacol"},{"key":"3868_CR123","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","volume":"105","author":"RCSR Danduga","year":"2018","unstructured":"Danduga RCSR et al (2018) Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats. Biomed Pharmacother 105:1254\u20131268","journal-title":"Biomed Pharmacother"},{"key":"3868_CR124","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuroscience.2014.12.018","volume":"287","author":"A Khan","year":"2015","unstructured":"Khan A et al (2015) Neuroprotective effect of hemeoxygenase-1\/glycogen synthase kinase-3\u03b2 modulators in 3-nitropropionic acid-induced neurotoxicity in rats. Neuroscience 287:66\u201377","journal-title":"Neuroscience"},{"issue":"12","key":"3868_CR125","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.4103\/1673-5374.165300","volume":"10","author":"G Burnstock","year":"2015","unstructured":"Burnstock G (2015) Purinergic signalling in neuroregeneration. Neural Regen Res 10(12):1919","journal-title":"Neural Regen Res"},{"issue":"1\u20132","key":"3868_CR126","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","volume":"92","author":"K Fuxe","year":"2007","unstructured":"Fuxe K et al (2007) Adenosine receptor\u2013dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 92(1\u20132):210\u2013217","journal-title":"Physiol Behav"},{"key":"3868_CR127","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuropharm.2015.04.001","volume":"98","author":"F Ciruela","year":"2015","unstructured":"Ciruela F, Fern\u00e1ndez-Due\u00f1as V, Jacobson KA (2015) Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. Neuropharmacology 98:58\u201367","journal-title":"Neuropharmacology"},{"issue":"19","key":"3868_CR128","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS et al (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14(19):2871\u20132880","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3868_CR129","first-page":"467","volume":"26","author":"Y-H Kao","year":"2017","unstructured":"Kao Y-H et al (2017) Targeting ENT1 and adenosine tone for the treatment of Huntington\u2019s disease. Hum Mol Genet 26(3):467\u2013478","journal-title":"Hum Mol Genet"},{"issue":"5","key":"3868_CR130","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1523\/JNEUROSCI.11-05-01375.1991","volume":"11","author":"K Yoon","year":"1991","unstructured":"Yoon K, Rothman S (1991) Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J Neurosci 11(5):1375\u20131380","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"3868_CR131","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0014-2999(94)90762-5","volume":"253","author":"DK Von Lubitz","year":"1994","unstructured":"Von Lubitz DK et al (1994) Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 253(1\u20132):95\u201399","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3868_CR132","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/jphysiol.2007.132613","volume":"582","author":"A Gundlfinger","year":"2007","unstructured":"Gundlfinger A et al (2007) Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels. J Physiol 582(1):263\u2013277","journal-title":"J Physiol"},{"issue":"3","key":"3868_CR133","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass M, Dragunow M, Faull R (2000) The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience 97(3):505\u2013519","journal-title":"Neuroscience"},{"issue":"3","key":"3868_CR134","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1006\/nbdi.2002.0512","volume":"10","author":"D Blum","year":"2002","unstructured":"Blum D et al (2002) Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington\u2019s disease. Neurobiol Dis 10(3):410\u2013426","journal-title":"Neurobiol Dis"},{"issue":"7","key":"3868_CR135","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","volume":"15","author":"K Varani","year":"2001","unstructured":"Varani K et al (2001) Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin. FASEB J 15(7):1245\u20131247","journal-title":"FASEB J"},{"issue":"1","key":"3868_CR136","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"S Tabrizi","year":"1999","unstructured":"Tabrizi S et al (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45(1):25\u201332","journal-title":"Ann Neurol"},{"issue":"7","key":"3868_CR137","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0166-2236(00)01584-8","volume":"23","author":"MF Beal","year":"2000","unstructured":"Beal MF (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23(7):298\u2013304","journal-title":"Trends Neurosci"},{"issue":"3","key":"3868_CR138","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.1991.tb08257.x","volume":"57","author":"SN Schiffmann","year":"1991","unstructured":"Schiffmann SN, Jacobs O, Vanderhaeghen JJ (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57(3):1062\u20131067","journal-title":"J Neurochem"},{"issue":"3","key":"3868_CR139","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0169-328X(92)90173-9","volume":"14","author":"JS Fink","year":"1992","unstructured":"Fink JS et al (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Mol Brain Res 14(3):186\u2013195","journal-title":"Mol Brain Res"},{"issue":"3","key":"3868_CR140","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W","volume":"431","author":"BD Hettinger","year":"2001","unstructured":"Hettinger BD et al (2001) Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 431(3):331\u2013346","journal-title":"J Comp Neurol"},{"issue":"1\u20132","key":"3868_CR141","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0169-328X(02)00216-4","volume":"102","author":"BS Spektor","year":"2002","unstructured":"Spektor BS et al (2002) Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington\u2019s disease. Mol Brain Res 102(1\u20132):118\u2013128","journal-title":"Mol Brain Res"},{"issue":"17","key":"3868_CR142","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1097\/00001756-199812010-00034","volume":"9","author":"A Monopoli","year":"1998","unstructured":"Monopoli A et al (1998) Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport 9(17):3955\u20133958","journal-title":"NeuroReport"},{"issue":"12","key":"3868_CR143","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","volume":"23","author":"D Blum","year":"2003","unstructured":"Blum D et al (2003) A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J Neurosci 23(12):5361\u20135369","journal-title":"J Neurosci"},{"issue":"1","key":"3868_CR144","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","volume":"17","author":"M Gianfriddo","year":"2004","unstructured":"Gianfriddo M et al (2004) Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice .Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol Dis 17(1):77\u201388","journal-title":"Neurobiol Dis"},{"issue":"34","key":"3868_CR145","doi-asserted-by":"publisher","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","volume":"23","author":"PD Alfinito","year":"2003","unstructured":"Alfinito PD et al (2003) Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci 23(34):10982\u201310987","journal-title":"J Neurosci"},{"issue":"3","key":"3868_CR146","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","volume":"88","author":"JS Fink","year":"2004","unstructured":"Fink JS et al (2004) Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem 88(3):538\u2013544","journal-title":"J Neurochem"},{"issue":"5","key":"3868_CR147","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12640-021-00401-6","volume":"39","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021) Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases. Neurotox Res 39(5):1630\u20131650","journal-title":"Neurotox Res"},{"issue":"3","key":"3868_CR148","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157488912803252023","volume":"7","author":"G Joshi","year":"2012","unstructured":"Joshi G, Johnson JA (2012) The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 7(3):218\u2013229","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"3","key":"3868_CR149","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/aps.2014.107","volume":"36","author":"Y Gao","year":"2015","unstructured":"Gao Y et al (2015) Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington\u2019s disease. Acta Pharmacol Sin 36(3):311\u2013322","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"3868_CR150","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0047-6374(03)00083-6","volume":"124","author":"C-C Hsieh","year":"2003","unstructured":"Hsieh C-C, Rosenblatt JI, Papaconstantinou J (2003) Age-associated changes in SAPK\/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. Mech Ageing Dev 124(6):733\u2013746","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"3868_CR151","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.freeradbiomed.2011.04.019","volume":"51","author":"X Wang","year":"2011","unstructured":"Wang X et al (2011) ROS-activated p38 MAPK\/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radical Biol Med 51(2):539\u2013551","journal-title":"Free Radical Biol Med"},{"issue":"24","key":"3868_CR152","doi-asserted-by":"publisher","first-page":"22925","DOI":"10.1074\/jbc.M414635200","volume":"280","author":"AY Shih","year":"2005","unstructured":"Shih AY et al (2005) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280(24):22925\u201322936","journal-title":"J Biol Chem"},{"key":"3868_CR153","doi-asserted-by":"publisher","first-page":"105067","DOI":"10.1016\/j.neuint.2021.105067","volume":"147","author":"A Sharma","year":"2021","unstructured":"Sharma A, Mehan S (2021) Targeting PI3K-AKT\/mTOR signaling in the prevention of autism. Neurochem Int 147:105067","journal-title":"Neurochem Int"},{"issue":"9","key":"3868_CR154","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","volume":"20","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515\u2013534","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3868_CR155","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/jcp.27262","volume":"234","author":"M Jafari","year":"2019","unstructured":"Jafari M et al (2019) PI3k\/AKT signaling pathway: erythropoiesis and beyond. J Cell Physiol 234(3):2373\u20132385","journal-title":"J Cell Physiol"},{"issue":"3","key":"3868_CR156","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN et al (2019) The role of PI3K\/Akt and ERK in neurodegenerative disorders. Neurotox Res 35(3):775\u2013795","journal-title":"Neurotox Res"},{"issue":"1","key":"3868_CR157","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F et al (2020) Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 10(1):54","journal-title":"Cell Biosci"},{"key":"3868_CR158","doi-asserted-by":"publisher","first-page":"740966","DOI":"10.3389\/fphar.2021.740966","volume":"12","author":"A Mustafa","year":"2021","unstructured":"Mustafa A et al (2021) Inhibition of Brain GTP cyclohydrolase I attenuates 3-nitropropionic acid-induced striatal toxicity: involvement of Mas receptor\/PI3k\/Akt\/CREB\/BDNF axis. Front Pharmacol 12:740966","journal-title":"Front Pharmacol"},{"issue":"3","key":"3868_CR159","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbrc.2015.08.075","volume":"465","author":"KJ Cho","year":"2015","unstructured":"Cho KJ, Kim GW (2015) Differential caspase activity in the cortex and striatum with chronic infusion of 3-nitropropionic acid. Biochem Biophys Res Commun 465(3):631\u2013637","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"3868_CR160","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.pnpbp.2011.09.005","volume":"35","author":"I Tasset","year":"2011","unstructured":"Tasset I et al (2011) Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels. Prog Neuropsychopharmacol Biol Psychiatry 35(8):1944\u20131949","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3868_CR161","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mcn.2018.12.002","volume":"94","author":"J Saba","year":"2019","unstructured":"Saba J et al (2019) Melanocortin 4 receptor activation protects striatal neurons and glial cells from 3-nitropropionic acid toxicity. Mol Cell Neurosci 94:41\u201351","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"3868_CR162","first-page":"687","volume":"69","author":"S Xiaoyan","year":"2020","unstructured":"Xiaoyan S et al (2020) Follicle stimulating hormone inhibits the expression of p53 up-regulated modulator of apoptosis induced by reactive oxygen species through PI3K\/AKT in mouse granulosa cells. Physiol Res 69(4):687","journal-title":"Physiol Res"},{"issue":"6","key":"3868_CR163","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/jnc.13937","volume":"140","author":"CL Wu","year":"2017","unstructured":"Wu CL et al (2017) Roles of p62 in BDNF-dependent autophagy suppression and neuroprotection against mitochondrial dysfunction in rat cortical neurons. J Neurochem 140(6):845\u2013861","journal-title":"J Neurochem"},{"key":"3868_CR164","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","volume":"118","author":"HN Shalaby","year":"2018","unstructured":"Shalaby HN, El-Tanbouly DM, Zaki HF (2018) Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors. Food Chem Toxicol 118:227\u2013234","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"3868_CR165","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/jnr.23060","volume":"90","author":"J Duran-Vilaregut","year":"2012","unstructured":"Duran-Vilaregut J et al (2012) Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3\u03b2 in the striatum of rats treated with 3-nitropropionic acid. J Neurosci Res 90(9):1803\u20131813","journal-title":"J Neurosci Res"},{"issue":"4","key":"3868_CR166","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2990.2011.01214.x","volume":"38","author":"F Junyent","year":"2012","unstructured":"Junyent F et al (2012) Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid. Neuropathol Appl Neurobiol 38(4):311\u2013321","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"3868_CR167","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2010.01.013","volume":"38","author":"E Puerta","year":"2010","unstructured":"Puerta E et al (2010) Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. Neurobiol Dis 38(2):237\u2013245","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3868_CR168","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s12035-015-9303-2","volume":"53","author":"LA Ahmed","year":"2016","unstructured":"Ahmed LA et al (2016) Role of rho kinase inhibition in the protective effect of fasudil and simvastatin against 3-nitropropionic acid-induced striatal neurodegeneration and mitochondrial dysfunction in rats. Mol Neurobiol 53(6):3927\u20133938","journal-title":"Mol Neurobiol"},{"issue":"9","key":"3868_CR169","doi-asserted-by":"publisher","first-page":"e0203837","DOI":"10.1371\/journal.pone.0203837","volume":"13","author":"H El-Abhar","year":"2018","unstructured":"El-Abhar H et al (2018) Cilostazol disrupts TLR-4, Akt\/GSK-3\u03b2\/CREB, and IL-6\/JAK-2\/STAT-3\/SOCS-3 crosstalk in a rat model of Huntington\u2019s disease. PLoS ONE 13(9):e0203837","journal-title":"PLoS ONE"},{"issue":"2","key":"3868_CR170","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","volume":"217","author":"J Rossignol","year":"2011","unstructured":"Rossignol J et al (2011) Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes. Behav Brain Res 217(2):369\u2013378","journal-title":"Behav Brain Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03868-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T12:23:57Z","timestamp":1728822237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03868-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3868"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03868-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"15 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}